Cancer diagnosis using label-free SERS-based exosome analysis
Theranostics · 2024 · 14 (5) · 1966-1981
DOI: 10.7150/thno.92621 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, 2024. Verfasst von Yajuan Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Molecular Target & Clinical Pharmacology, and the NMPA & State Key Laboratory of Respiratory Disease, School of Pharmaceutical Scie…. Hauptthemen laut MEDLINE: Exosomes, Neoplasms. Die Arbeit wurde bisher 107-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Molecular Target & Clinical Pharmacology, and the NMPA & State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences & the Fifth Affiliated Hospital, Guangzhou Medical University, 51…
- School of Chemistry and Chemical Engineering, Guizhou University, 550025, Guiyang, China.
- Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
Zitieren
APA
Liu, Y., Li, M., Liu, H., Kang, C., & Wang, C. (2024). Cancer diagnosis using label-free SERS-based exosome analysis. Theranostics, 14(5), 1966-1981. https://doi.org/10.7150/thno.92621
Vancouver
Liu Y, Li M, Liu H, Kang C, Wang C. Cancer diagnosis using label-free SERS-based exosome analysis. Theranostics. 2024;14(5):1966-1981. doi:10.7150/thno.92621
BibTeX
@article{Liu2024,
author = {Liu, Yajuan and Li, Mei and Liu, Haisha and Kang, Chao and Wang, Cheng},
title = {Cancer diagnosis using label-free SERS-based exosome analysis},
journal = {Theranostics},
year = {2024},
volume = {14},
number = {5},
pages = {1966--1981},
doi = {10.7150/thno.92621}
}
EUVIMED